Proposal of remission criteria for IgA nephropathy

被引:0
作者
Yusuke Suzuki
Keiichi Matsuzaki
Hitoshi Suzuki
Naoko Sakamoto
Kensuke Joh
Tetsuya Kawamura
Yasuhiko Tomino
Seiichi Matsuo
机构
[1] Juntendo University,Division of Nephrology, Department of Internal Medicine, Faculty of Medicine
[2] National Research Institute for Child Health and Development,Department of Pathology
[3] Sendai Shakaihoken Hospital,Division of Kidney and Hypertension, Department of Internal Medicine
[4] Jikei University School of Medicine,Division of Nephrology, Department of Internal Medicine, Faculty of Medicine
[5] University of Nagoya,undefined
来源
Clinical and Experimental Nephrology | 2014年 / 18卷
关键词
Remission criteria; IgA nephropathy; Hematuria; Proteinuria;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:481 / 486
页数:5
相关论文
共 40 条
  • [1] Koyama A(1997)Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases Am J Kidney Dis 29 526-532
  • [2] Igarashi M(1999)Corticosteroids in IgA nephropathy: a randomised controlled trial Lancet 353 883-887
  • [3] Kobayashi M(2001)Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy Am J Kidney Dis 38 736-743
  • [4] Pozzi C(2007)Remission of proteinuria improves prognosis in IgA nephropathy J Am Soc Nephrol 18 3177-3183
  • [5] Bolasco PG(2010)Predictors for progression in immunoglobulin A nephropathy with significant proteinuria Nephrology 15 236-241
  • [6] Fogazzi GB(2012)Complete remission within 2 years predicts a good prognosis after methylprednisolone pulse therapy in patients with IgA nephropathy Clin Exp Nephrol 16 883-891
  • [7] Hotta O(2008)Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study Hypertens Res 31 433-441
  • [8] Miyazaki M(2003)Proteinuria and the risk of developing end-stage renal disease Kidney Int 63 1468-1474
  • [9] Furuta T(2004)Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial J Am Soc Nephrol 15 157-163
  • [10] Reich HN(2006)Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study Am J Kidney Dis 47 751-760